Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer1This work was presented in part at the 17th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas, USA, December 8–10, 1994 and the Annual Meeting of The American Society of Clinical Oncology in Los Angeles, California, USA, May 20–23, 1995.1

BACKGROUND: The primary objective of this study was to develop a decision aid which would encourage and assist patients to become involved in treatment decision making, and help clinicians to objectively educate patients about the benefits and risks of adjuvant chemotherapy for breast cancer. A secondary objective was to investigate the factors influencing this treatment decision-making process for women when choosing between adriamycin and …